High-dose vitamin D for intensive care patients with sepsis
Treatments studied
Part of Infections clinical trials.
This study tests whether giving very high doses of vitamin D to patients with sepsis in the intensive care unit (ICU) can improve their recovery. It focuses on adults aged 18 and older who have just been diagnosed with sepsis and are expected to stay in the ICU for at least a week.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and have been diagnosed with sepsis.
- You were moved to the intensive care unit (ICU) within 24 hours of the sepsis diagnosis.
- Your severity of illness score (APACHE II) is between 15 and 40.
- The ICU doctors expect you will need to stay in the ICU for at least 7 days.
- You have not taken more than 2000 IU of vitamin D per day or a single dose of 10,000 IU in the last month.
- You do not have certain medical conditions like severe liver disease, active cancer, or recent kidney stones, and you weigh between 45 and 90 kg (about 99 to 198 pounds).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special form of vitamin D can improve outcomes for patients with sepsis, a severe infection that can cause organ failure. The treatment is given to patients in the intensive care unit, and the study aims to see if it helps them recover better.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
This study looks at whether ionized calcium levels (a form of calcium in your blood) can help show how severe your sepsis is. By measuring it early, doctors might better understand your condition and guide treatment.
This trial tests if curcumin (a natural compound found in turmeric) can help critically ill patients fighting sepsis, a life-threatening response to infection. It is for adults who are already receiving food through a feeding tube in the ICU.
This trial studies a quick set of tests to figure out whether a person with severe infection (sepsis) will respond to corticosteroids like hydrocortisone. The goal is to guide treatment sooner and avoid ineffective care.
This study looks at how your immune cells respond during a severe infection in the ICU. It aims to better predict how the infection will progress and help tailor treatment.
Hear when a new Critically Ill trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.